These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1958 related articles for article (PubMed ID: 26494508)

  • 1. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seabuckthorn berry polysaccharide protects against carbon tetrachloride-induced hepatotoxicity in mice via anti-oxidative and anti-inflammatory activities.
    Zhang W; Zhang X; Zou K; Xie J; Zhao S; Liu J; Liu H; Wang J; Wang Y
    Food Funct; 2017 Sep; 8(9):3130-3138. PubMed ID: 28766672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
    Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
    Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice.
    Gong X; Yang Y; Huang L; Zhang Q; Wan RZ; Zhang P; Zhang B
    Int Immunopharmacol; 2017 May; 46():124-132. PubMed ID: 28282576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Tian Y; Li Z; Shen B; Zhang Q; Feng H
    Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
    Lyu Z; Ji X; Chen G; An B
    Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
    Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
    Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
    Cho HI; Park JH; Choi HS; Kwak JH; Lee DU; Lee SK; Lee SM
    J Nat Prod; 2014 Nov; 77(11):2497-503. PubMed ID: 25382719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Yang XF; He Y; Li HY; Liu X; Chen H; Liu JB; Ji WJ; Wang B; Chen LN
    Mol Med Rep; 2014 Jul; 10(1):555-9. PubMed ID: 24788561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
    Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qingchangligan formula attenuates the inflammatory response to protect the liver from acute failure induced by d-galactosamine/lipopolysaccharide in mice.
    Zhang X; Ding J; Gou C; Wen T; Li L; Wang X; Yang H; Liu D; Lou J; Chen D; Ren F; Li X
    J Ethnopharmacol; 2017 Apr; 201():108-116. PubMed ID: 27833028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
    Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
    Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
    Li Y; Wang N; Jiang Y
    Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.